Compare MYFW & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYFW | TMCI |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.1M | 279.6M |
| IPO Year | 2018 | 2021 |
| Metric | MYFW | TMCI |
|---|---|---|
| Price | $31.84 | $4.68 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $27.00 | $4.77 |
| AVG Volume (30 Days) | 60.4K | ★ 375.6K |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.02 | N/A |
| EPS | ★ 1.20 | N/A |
| Revenue | $96,914,000.00 | ★ $212,690,000.00 |
| Revenue This Year | $20.48 | N/A |
| Revenue Next Year | $9.70 | $8.18 |
| P/E Ratio | $26.40 | ★ N/A |
| Revenue Growth | ★ 7.60 | 1.59 |
| 52 Week Low | $20.40 | $1.17 |
| 52 Week High | $34.36 | $7.78 |
| Indicator | MYFW | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 48.18 | 52.55 |
| Support Level | $27.71 | $3.84 |
| Resistance Level | $34.03 | $4.67 |
| Average True Range (ATR) | 1.15 | 0.28 |
| MACD | -0.13 | 0.02 |
| Stochastic Oscillator | 51.88 | 52.48 |
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.